Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Anticancer Drugs. 2012 Nov;23(10):1054–1066. doi: 10.1097/CAD.0b013e32835739dd

Figure 2.

Figure 2

Effect of HDAC inhibition on cell cycle and apoptosis. (A) NBL-W-N cell line was treated with either 2.5 mM of VPA or vehicle control for 2 days and analyzed by flow cytometry. Each column represents the mean of three independent experiments. (B) LA1-55n cell line was treated with either 2.5 mM of VPA or vehicle control for 2 days and analyzed by flow cytometry. (C) NBL-W-N cells were treated with 2.5 mM VPA for 1 day and subjected to caspase 3/7 activity assay. (D) LA1-55n cells were treated with 2.5 mM VPA for 1 day and caspase 3/7 activity between control and VPA-treated samples were measured. * p<0.05 compared to control